PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsOmeprazole
Omeprazole
Konvomep, Omeclamox-pak, Omeprazole, Prilosec, Talicia, Yosprala, Zegerid (omeprazole) is a small molecule pharmaceutical. Omeprazole was first approved as Prilosec on 1989-09-14. It is used to treat duodenal ulcer, esophagitis, gastroesophageal reflux, heartburn, and helicobacter infections amongst others in the USA. The pharmaceutical is active against potassium-transporting ATPase alpha chain 1. In addition, it is known to target chloride channel protein 2.
Download report
Favorite
Top Prescription Drugs
Searched
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
neoplasmsD009369
digestive system diseasesD004066
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Omeprazole, Omeprazole magnesium, Prilosec (discontinued: Omeprazole, Omeprazole magnesium, Prilosec)
Combinations
Konvomep, Omeprazole bicarbonate, Talicia, Zegerid (discontinued: Magnesium hydroxide omeprazole bicarbonate, Omeclamox-pak, Omeprazole bicarbonate, Yosprala, Zegerid)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Omeprazole
+
Sodium bicarbonate
Tradename
Company
Number
Date
Products
KONVOMEPAzurityN-213593 RX2022-08-30
1 products, RLD, RS
ZEGERID OTCRiley Consumer Care HoldingsN-022281 OTC2009-12-01
1 products, RLD, RS
ZEGERID OTCRiley Consumer Care HoldingsN-022283 OTC2013-06-17
1 products, RLD, RS
Show 2 discontinued
Omeprazole
Tradename
Company
Number
Date
Products
OMEPRAZOLEDexcel PharmaN-209400 OTC2017-07-05
1 products, RLD, RS
OMEPRAZOLEDexcel PharmaN-022032 OTC2007-12-04
1 products, RLD, RS
Show 1 discontinued
Aspirin
+
Omeprazole
Tradename
Company
Number
Date
Products
YOSPRALAGenus LifesciencesN-205103 DISCN2016-09-14
2 products, RLD
Hide discontinued
Amoxicillin
+
Clarithromycin
+
Omeprazole
Tradename
Company
Number
Date
Products
OMECLAMOX-PAKCumberland PharmaceuticalsN-050824 DISCN2011-02-08
1 products, RLD
Hide discontinued
Magnesium hydroxide
+
Omeprazole
+
Sodium bicarbonate
Tradename
Company
Number
Date
Products
MAGNESIUM HYDROXIDE AND OMEPRAZOLE AND SODIUM BICARBONATESantarusN-022456 DISCN2009-12-04
2 products
ZEGERIDSantarusN-021850 DISCN2006-03-24
2 products
Hide discontinued
Amoxicillin
+
Omeprazole magnesium
+
Rifabutin
Tradename
Company
Number
Date
Products
TALICIARedHill BiopharmaN-213004 RX2019-11-01
1 products, RLD, RS
Omeprazole magnesium
Tradename
Company
Number
Date
Products
PRILOSEC OTCAstraZenecaN-021229 OTC2003-06-20
1 products, RLD, RS
PRILOSECCovis PharmaN-022056 RX2008-03-20
2 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
24 hr omeprazoleNew Drug Application2025-01-14
acid reducerANDA2025-07-23
acid reducer powderANDA2025-03-03
amazon basic care omeprazoleANDA2024-05-10
aspirin and omeprazole delayed-release tabNew Drug Application2019-11-20
basic care omeprazoleNew Drug Application2025-09-22
basic care omeprazole and sodium bicarbonateANDA2021-07-22
berkley and jensen omeprazoleNew Drug Application2025-03-06
care one omeprazoleNew Drug Application2025-02-06
careone omeprazoleNew Drug Application2025-04-17
Show 50 more
Agency Specific
FDA
EMA
Expiration
Code
AMOXICILLIN / OMEPRAZOLE MAGNESIUM / RIFABUTIN, TALICIA, REDHILL
2027-11-01GAIN
2022-11-01NP
Patent Expiration
Patent
Expires
Flag
FDA Information
Amoxicillin / Omeprazole Magnesium / Rifabutin, Talicia, Redhill
118780112042-05-27U-3816
90502632034-02-12DPU-2660
94984452034-02-12DPU-2660
96038062034-02-12DPU-2660
102386062034-02-12DP
111351722034-02-12DPU-2660
Omeprazole / Sodium Bicarbonate, Konvomep, Azurity
117716862040-03-01U-623
107513332039-07-16DP
111034922039-07-16DP
116334782039-07-16DP
Omeprazole, Omeprazole, Dexcel
100764942036-12-08DP
108354882036-12-08DP
Aspirin / Omeprazole, Yosprala, Genus Lifesciences
95392142033-03-13U-1902
99872312033-01-02U-2324
Omeprazole, Omeprazole, Dexcel Pharma
90233912025-08-16DP
ATC Codes
A: Alimentary tract and metabolism drugs
A02: Drugs for acid related disorders
A02B: Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)
A02BC: Proton pump inhibitors for peptic ulcer and gord
A02BC01: Omeprazole
A02BD: Combinations for eradication of helicobacter pylori
A02BD01: Omeprazole, amoxicillin and metronidazole
A02BD05: Omeprazole, amoxicillin and clarithromycin
A02BD16: Omeprazole, amoxicillin and rifabutin
HCPCS
No data
Clinical
Clinical Trials
1002 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients1641196180
Gastroesophageal refluxD005764EFO_0003948K211724415236164
InfectionsD007239EFO_0000544119166830127
Helicobacter infectionsD016481EFO_10009612413291966
UlcerD014456MPATH_579562415756
Peptic esophagitisD004942EFO_10010953517101145
EsophagitisD004941HP_0100633K20451511943
Peptic ulcerD010437K2743922543
DyspepsiaD004415EFO_0008533K3047918642
Communicable diseasesD003141435181139
Show 122 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Diabetes mellitusD003920EFO_0000400E08-E13622110
RecurrenceD01200811214
GastrinomaD0154081113
Zollinger-ellison syndromeD015043E16.41113
PancreatitisD010195EFO_0000278K851113
AsthmaD001249EFO_0000270J45213
Human experimentationD00680533
Squamous cell carcinomaD002294213
Exocrine pancreatic insufficiencyD010188K86.811113
GranulomaD006099112
Show 54 more
Indications Phases 2
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PharmacokineticsD01059977
Hiv infectionsD015658EFO_0000764B2066
Drug-related side effects and adverse reactionsD064420T88.7134
Covid-19D000086382U07.1134
Therapeutic equivalencyD01381033
Alzheimer diseaseD000544EFO_0000249F0333
Chronic hepatitis bD019694EFO_0004239B18.133
MalnutritionD044342EFO_0008572E40-E4633
MelanomaD00854522
Sickle cell anemiaD000755EFO_0000697D5722
Show 63 more
Indications Without Phase
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOmeprazole
INNomeprazole
Description
6-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methylsulfinyl]-1H-benzimidazole is a member of benzimidazoles and a sulfoxide.
Classification
Small molecule
Drug classantiulcer agents (benzimidazole derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1
Identifiers
PDB
CAS-ID73590-58-6
RxCUI
ChEMBL IDCHEMBL1503
ChEBI ID77260
PubChem CID4594
DrugBankDB00338
UNII IDKG60484QX9 (ChemIDplus, GSRS)
Target
Agency Approved
ATP4A
ATP4A
Organism
Homo sapiens
Gene name
ATP4A
Gene synonyms
NCBI Gene ID
Protein name
potassium-transporting ATPase alpha chain 1
Protein synonyms
ATPase H+/K+ transporting alpha subunit, ATPase, H+/K+ exchanging, alpha polypeptide, ATPase, H+/K+ transporting, alpha polypeptide, epididymis secretory sperm binding protein, Gastric H(+)/K(+) ATPase subunit alpha, gastric H+/K+ ATPase alpha subunit, gastric H,K-ATPase catalytic subunit, gastric hydrogen-potassium ATPase, Proton pump
Uniprot ID
Mouse ortholog
Atp4a (11944)
potassium-transporting ATPase alpha chain 1 (Q9CV46)
Alternate
CLCN2
CLCN2
Organism
Homo sapiens
Gene name
CLCN2
Gene synonyms
NCBI Gene ID
Protein name
chloride channel protein 2
Protein synonyms
chloride channel 2, chloride channel, voltage-sensitive 2
Uniprot ID
Mouse ortholog
Clcn2 (12724)
chloride channel protein 2 (Q9WUJ9)
Variants
No data
Financial
Revenue by drug
$
£
Prilosec AstraZeneca
Plot placeholder
Mock data
Subscribe for the real data
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Estimated US medical usage
Omeprazole
+
Amoxicillin
+
Clarithromycin
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Omeprazole
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 28,360 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
155,866 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use